705 / 923
Long-term morbidity rate is low. (LoE: III)
Technical advances improve tumor control and
lower toxicity.
Careful patient selection is important to avoid
unacceptable morbidity.
Urgent need for prospective trials to investigate
on medical approaches to the treatment of
morbidity.
Summary of first presentation